Signaling Pathway
Ansuvimab-zyk is a recombinant human monoclonal IgG1 antibody designed to target and neutralize Zaire ebolavirus. It functions by specifically binding to the viral glycoprotein, thereby inhibiting the virus's ability to enter and infect host cells. This interaction is crucial for preventing the spread of infection and is a key mechanism in its antiviral efficacy against Zaire ebolavirus.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Ansuvimab-zyk is a recombinant human monoclonal IgG1 antibody designed to target and neutralize Zaire ebolavirus. It functions by specifically binding to the viral glycoprotein, thereby inhibiting the virus's ability to enter and infect host cells. This interaction is crucial for preventing the spread of infection and is a key mechanism in its antiviral efficacy against Zaire ebolavirus. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
